title: Utility and Limitations of Large Population-Based Data for Skin Cancer Outcomes.
abstract: Large population-based studies are useful for determining cancer outcomes, but interpreting their findings requires understanding their limitations. Youlden et al. highlight the utility of using a large dataset for studying melanoma survival, whereas Gimotty et al. point out the limitations of such datasets in miscoding thickness, a key prognostic variable. Awareness of limitations of population-based registry data can help to inform their interpretations and clinical implications.
authors: Department of Dermatology, Massachusetts General Hospital, and Department of Population Medicine, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: harvardskinstudies@partners.org.
authors: Maryam M
authors: MM
authors: Asgari
mesh_terms: D016208:Databases, Factual; D014943:Global Health; D006801:Humans; D009017:Morbidity / Q000639:trends; D011159:Population Surveillance; D011379:Prognosis; D012042:Registries; D012878:Skin Neoplasms / Q000453:epidemiology*; D015996:Survival Rate / Q000639:trends